About Us
Your full-service clinical Contract Research Organization (CRO)
One-stop shop
our integrated approach to your product development programme ensures efficient translation from the in-vitro and preclinical stages through to Proof of Concept.
An all In-house approach
By virtue of Eurofins’ worldwide network of laboratories and dedicated GxP Pharma sites, underpinned by its robust QA programme, we are in an unrivalled position to undertake internally the entire spectrum of activities required to direct and support clinical trials. This allows us to optimize the time and cost of your clinical development projects.
Over three decades dedicated to clinical trials
Our team
A human-scale team with global reach
The Eurofins Optimed team of clinical trial experts is also your point of access to Eurofins’ Biopharma division, a first-class biopharmaceutical outsourcing services organization (Contract Research Organization – CRO and Contract Development & Manufacturing Organization - CDMO), offering a holistic approach to cover the entire chain of compound development in order to maximize your chances to succeed in the clinical stages.
Robust and close-knit management team
Our President and Medical Director, Dr. Yves Donazzolo together with our Head of Clinical Operations, Dr. Mathilde Latreille, founded Optimed in 1990 and have been continuously working hand-in-hand since then.
Yves and Mathilde together have, not only successfully directed the most technically demanding clinical trials in the most challenging indications, but have also built a successful, innovative and prosperous company.
Optimed joined the Eurofins family in 2006 ,which represented a well-deserved acknowledgement of many years of intelligent decision-making, resilience and hard work
Yves Donazzolo
MD, Msc, Clinical Pharmacologist
President, CEO &
Medical Director
Mathilde Latreille
MD
Head of Clinical Trials
Yves
Yves gained a medical degree from the University of Grenoble as well as a number of other higher education certificates and post graduate degrees in Clinical Research and other related disciplines, including Clinical Pharmacology and Metabolism, Biology and Medical Sciences (University of Nancy), and Applied Statistics (University of Paris).
From the late 1980s until the early 2000s, he worked as an Emergency Physician at the University Hospital of Grenoble and he was also a member of the Grenoble Ethics Committee.
Yves teaches in several programmes in Clinical Pharmacology and Drug Development at the University of Grenoble and is an active member of numerous scientific societies, such as the French Association of Translational Pharmacology (AFPT), the European Federation for Exploratory Medicines Development( EUFEMED), the French Society of Pharmacology and Therapeutics (SFPT), the British Pharmacological Society (BPS) and the American College for Clinical Pharmacology (ACCP).
In addition, he is regularly appointed as member of Independent Data Monitoring Committees (IDMCs).
Mathilde
Since her graduation as Doctor of Medicine from the University of Grenoble in 1990, Mathilde has never stopped enhancing her expertise in medicine and clinical research. Applied statistics (University of Paris), Pharmacology (U. of Grenoble), Pharmacovigilance (IFIS), Emergency situations in clinical research, Regulatory affairs or ICH E6 (R2) Good Clinical Practice (Brookwood International Academy) are but a few of the higher education certificates and diplomas that accredit Mathilde’s robust and extensive mastery of the clinical research ecosystem.
